These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 32369604)

  • 1. Internationalization of read-across as a validated new approach method (NAM) for regulatory toxicology.
    Rovida C; Barton-Maclaren T; Benfenati E; Caloni F; Chandrasekera PC; Chesné C; Cronin MTD; De Knecht J; Dietrich DR; Escher SE; Fitzpatrick S; Flannery B; Herzler M; Hougaard Bennekou S; Hubesch B; Kamp H; Kisitu J; Kleinstreuer N; Kovarich S; Leist M; Maertens A; Nugent K; Pallocca G; Pastor M; Patlewicz G; Pavan M; Presgrave O; Smirnova L; Schwarz M; Yamada T; Hartung T
    ALTEX; 2020; 37(4):579-606. PubMed ID: 32369604
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience.
    Moné MJ; Pallocca G; Escher SE; Exner T; Herzler M; Bennekou SH; Kamp H; Kroese ED; Leist M; Steger-Hartmann T; van de Water B
    Arch Toxicol; 2020 Oct; 94(10):3581-3592. PubMed ID: 32886186
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project.
    Escher SE; Kamp H; Bennekou SH; Bitsch A; Fisher C; Graepel R; Hengstler JG; Herzler M; Knight D; Leist M; Norinder U; Ouédraogo G; Pastor M; Stuard S; White A; Zdrazil B; van de Water B; Kroese D
    Arch Toxicol; 2019 Dec; 93(12):3643-3667. PubMed ID: 31781791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NAM-supported read-across: From case studies to regulatory guidance in safety assessment.
    Rovida C; Escher SE; Herzler M; Bennekou SH; Kamp H; Kroese DE; Maslankiewicz L; Moné MJ; Patlewicz G; Sipes N; Van Aerts L; White A; Yamada T; Van de Water B
    ALTEX; 2021; 38(1):140-150. PubMed ID: 33452529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment.
    Alexander-White C; Bury D; Cronin M; Dent M; Hack E; Hewitt NJ; Kenna G; Naciff J; Ouedraogo G; Schepky A; Mahony C; Europe C
    Regul Toxicol Pharmacol; 2022 Mar; 129():105094. PubMed ID: 34990780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Automated integration of structural, biological and metabolic similarities to improve read-across.
    Gadaleta D; Golbamaki Bakhtyari A; Lavado GJ; Roncaglioni A; Benfenati E
    ALTEX; 2020; 37(3):469-481. PubMed ID: 32388568
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Read-across approaches: current applications and regulatory acceptance in Korea, Japan, and China.
    Lee BM; Lee SH; Yamada T; Park S; Wang Y; Kim KB; Kwon S
    J Toxicol Environ Health A; 2022 Mar; 85(5):184-197. PubMed ID: 34670481
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Integration of QSAR and NAM in the Read-Across Process for an Effective and Relevant Toxicological Assessment.
    Rovida C; Muscarella M; Locatelli M
    Methods Mol Biol; 2025; 2834():89-111. PubMed ID: 39312161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relevance and Application of Read-Across - Mini Review of European Consensus Platform for Alternatives and Scandinavian Society for Cell Toxicology 2017 Workshop Session.
    Stuard SB; Heinonen T
    Basic Clin Pharmacol Toxicol; 2018 Sep; 123 Suppl 5():37-41. PubMed ID: 29524304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toward Good Read-Across Practice (GRAP) guidance.
    Ball N; Cronin MT; Shen J; Blackburn K; Booth ED; Bouhifd M; Donley E; Egnash L; Hastings C; Juberg DR; Kleensang A; Kleinstreuer N; Kroese ED; Lee AC; Luechtefeld T; Maertens A; Marty S; Naciff JM; Palmer J; Pamies D; Penman M; Richarz AN; Russo DP; Stuard SB; Patlewicz G; van Ravenzwaay B; Wu S; Zhu H; Hartung T
    ALTEX; 2016; 33(2):149-66. PubMed ID: 26863606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Read-across approaches--misconceptions, promises and challenges ahead.
    Patlewicz G; Ball N; Becker RA; Booth ED; Cronin MT; Kroese D; Steup D; van Ravenzwaay B; Hartung T
    ALTEX; 2014; 31(4):387-96. PubMed ID: 25368965
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incorporating integrated testing strategy (ITSv1) defined approach into read-across (RAx) in predicting skin sensitization potency: ITSv1-based RAx.
    Nakayama K; Zifle A; Fritz S; Fuchs A; Sakaguchi H; Miyazawa M
    Regul Toxicol Pharmacol; 2023 Mar; 139():105358. PubMed ID: 36805910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EU-ToxRisk method documentation, data processing and chemical testing pipeline for the regulatory use of new approach methods.
    Krebs A; van Vugt-Lussenburg BMA; Waldmann T; Albrecht W; Boei J; Ter Braak B; Brajnik M; Braunbeck T; Brecklinghaus T; Busquet F; Dinnyes A; Dokler J; Dolde X; Exner TE; Fisher C; Fluri D; Forsby A; Hengstler JG; Holzer AK; Janstova Z; Jennings P; Kisitu J; Kobolak J; Kumar M; Limonciel A; Lundqvist J; Mihalik B; Moritz W; Pallocca G; Ulloa APC; Pastor M; Rovida C; Sarkans U; Schimming JP; Schmidt BZ; Stöber R; Strassfeld T; van de Water B; Wilmes A; van der Burg B; Verfaillie CM; von Hellfeld R; Vrieling H; Vrijenhoek NG; Leist M
    Arch Toxicol; 2020 Jul; 94(7):2435-2461. PubMed ID: 32632539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Highlight report: Launch of a large integrated European in vitro toxicology project: EU-ToxRisk.
    Daneshian M; Kamp H; Hengstler J; Leist M; van de Water B
    Arch Toxicol; 2016 May; 90(5):1021-4. PubMed ID: 27017488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A critical appraisal of the process of regulatory implementation of novel in vivo and in vitro methods for chemical hazard and risk assessment.
    Piersma AH; Ezendam J; Luijten M; Muller JJ; Rorije E; van der Ven LT; van Benthem J
    Crit Rev Toxicol; 2014 Nov; 44(10):876-94. PubMed ID: 25058877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New approach methodologies (NAMs) for human-relevant biokinetics predictions. Meeting the paradigm shift in toxicology towards an animal-free chemical risk assessment.
    Punt A; Bouwmeester H; Blaauboer BJ; Coecke S; Hakkert B; Hendriks DFG; Jennings P; Kramer NI; Neuhoff S; Masereeuw R; Paini A; Peijnenburg AACM; Rooseboom M; Shuler ML; Sorrell I; Spee B; Strikwold M; Van der Meer AD; Van der Zande M; Vinken M; Yang H; Bos PMJ; Heringa MB
    ALTEX; 2020; 37(4):607-622. PubMed ID: 32521035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lessons learned from validation of in vitro toxicity test: from failure to acceptance into regulatory practice.
    Spielmann H; Liebsch M
    Toxicol In Vitro; 2001; 15(4-5):585-90. PubMed ID: 11566595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toxicology testing steps towards computers.
    Kling J
    Lab Anim (NY); 2019 Feb; 48(2):40-42. PubMed ID: 30643278
    [No Abstract]   [Full Text] [Related]  

  • 19. In vitro tests within the REACH information strategies.
    Louekari K; Sihvonen K; Kuittinen M; Sømnes V
    Altern Lab Anim; 2006 Aug; 34(4):377-86. PubMed ID: 16945005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incorporating lines of evidence from New Approach Methodologies (NAMs) to reduce uncertainties in a category based read-across: A case study for repeated dose toxicity.
    Pestana CB; Firman JW; Cronin MTD
    Regul Toxicol Pharmacol; 2021 Mar; 120():104855. PubMed ID: 33359265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.